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Studies of the Repair of 06-Alkylguanine
and 04-Alkylthymine in DNA by
Alkyltransferases from Mammalian Cells
and Bacteria
by Anthony E. Pegg,* M. Eileen Dolan,* David
Scicchitano,* and Kazushige Morimoto*
06-Methylguanine in DNA is repaired by the action of a protein termed 06-alkylguanine-DNA alkyl-
transferase (AT) which transfers the methyl group to a cysteine residue in its own sequence. Since the
cysteine which is methylated is not regenerated rapidly, if at all, the capacity for repair of 06-methyl-
guanine is limited bythe number ofmolecules oftheATavailable withinthe cell. The level and inducibility
ofthe AT differed greatly in different mammalian cell types and species with the highest levels in human
tissues and in liver and the lowest levels in brain. Only a small induction occurred in rat liver in response
to exposure to alkylating agents. In E. coli such exposure increased the activity more than 100-fold. The
AT was not specific for methyl groups but also removed ethyl, 2-hydroxyethyl, n-propyl, isopropyl and n-
butyl groups from the 06-position in DNA. The protein isolated from E. coli removed methyl groups much
more rapidly than the larger alkyl groups but the mammalian AT isolated from rat liver showed much
less difference in rate with adducts of different size. Ethyl and n-propyl groups were removed by the rat
liver AT only three to four times more slowly than methyl groups. Another important difference between
the bacterial and mammalian ATs is that the bacterial protein was also able to remove methyl groups
from the 04-position of thymine in methylated DNA or poly(dT) but the AT from rat liver or human
fibroblasts did not repair 04_methylthymidine. These results indicate that the results obtained with the
E. coli system may not be a suitable model for extrapolation to predictions of the effects of alkylating
agents in initiating tumors or mutations in mammalian cells.
Introduction
Dimethylnitrosamine and related carcinogens are
converted enzymatically into reactive alkylating agents
(1,2). Such alkylating agents act as mutagens and tumor
initiators by interaction with the cellular DNA. At least
12 sites in DNA are targets for alkylation by dialkyl-
nitrosamines and N-alkyl-N-nitroso-ureas, but there is
evidence that attacks on the oxygen atoms of guanine
and possibly also pyrimidines may be of particular im-
portance in mutagenesis and carcinogenesis (2-7).
06-Methylguanine in DNA is repaired by an unusual
mechanisminvolving a protein termed 06-alkylguanine-
DNA alkyltransferase (AT). AT reacts with DNA con-
taining 06-alkylguanine residues and catalyzes the
transfer of the alkyl group to a cysteine acceptor site
contained withinitsprotein sequence (8-16). Thistrans-
ferrestores the DNA structure tonormalwithin asingle
step but the AT protein becomes stoichiometrically in-
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activated because the alkylcysteine is not regenerated
rapidly if at all. Therefore, the number of 06-alkyl-
guanine adducts which can be repaired without waiting
for new AT to be synthesized is limited to the number
ofmoleculesofATpresent. The presentpaperdescribes
measurements of the amount of AT activity in various
mammalian cells types, studies ofthe inducibility ofAT
in rodent liver and comparisons ofthe specificity ofthe
E. coli and rat liver AT with respect to the size ofthe
alkyl group which can be removed and the alkylated
base which can be repaired.
Materials and Methods
Detailed descriptions ofthe preparation of mammal-
ian cell extracts containing AT and the assay of AT
activity using radioactive [3H]methylated-DNA sub-
strate are given in the literature (10,11,13,17-19). AT
was purified from E. coli strain BS21 as described by
Demple et al. (12). Alkylated DNA substrates were
prepared by reaction of the appropriate N-alkyl-N-ni-
trosourea with calf thymus DNA (13,20). QuantitationPEGG ET AL.
Table 1. 06-Alkylguanine-DNA alkyltransferase activity
in human and rodent tissues.a
Alkyltransferase activity, fnole/mg
Tissue Rat Human
Liver 115 940
Colon 21 260
Lung 54 120
Esophagus 29 220
Brain 10 76
Meningeoma N.M. 207
Neurinoma N.M. 143
aExperimental details are given in the literature (14,17,18).
ofunlabeled 06-alkylguanines by fluorescence detection
after separation by HPLC was as described by Pegg et
al. (20). The competition assay for AT activity in which
a known amount of AT is incubated with an unlabeled
alkylated DNA substrate for various times and the re-
maining AT activity quantitated by addition of
[3H]methylated DNA was carried out as described else-
where (20). The preparation of[3H]methylated poly (dT),
analysis ofmethylated poly (dT) or DNAformethylated
pyrimidinebasesand assayforlossof04-methylthymine
was as described by Dolan et al. (21).
Results and Discussion
Species and Tissue Distribution of AT
AT has been detected in all normal and tumor tissues
examined from both rats and humans but the amount
ofactivity found varies substantially (13-18,22-25). Even
allowing for the much greater individual variations in
the human samples (14,17,18,22-25), there is general
agreement that human tissue samples are much more
active than their rodent equivalents. Typical values from
assays carried out in our laboratory are shown in Table
1. It should be noted that these values are based on
homogenates oftissues which may contain many differ-
ent cell types and results are averages which may dis-
guise substantial differences between individual cells.
Also, mammalian cells vary substantially in size and
protein content and since the AT activities are ex-
pressed as a function of protein, the relative activities
oflarge cells such as hepatocytes are somewhat under-
estimated. In fact, AT activities of purified rat hepa-
tocyte preparations were about five times as high as
those of isolated nonparenchymal cells (26).
Anumber ofhuman cultured celllines have been shown
to have little or no ATactivity (15,19,27-30). Such lines
termed mer (28-30) are very much more sensitive to
toxicity and mutagenesis by alkylating agents than the
equivalentmer+ lineswhichhavehighATlevels(19,28-
30). The mer phenotype has frequently been found in
transformed-cell lines (30), but some established "nor-
mal" human fibroblasts have recently been found to lack
AT activity (19), so the characteristic is not limited to
malignant cells. Since 25-30% ofthe human tumor cells
lines which have beentestedwere foundtobemer- (30),
itappearedpossiblethatasignificantnumberofprimary
tumors might also lack AT activity. This could render
them more sensitive to therapeutic alkylating agents
which produce lesions repairable by the AT (31-35).
Unfortunately, this does not appear to be the case since
examination of the AT activity of extracts from a con-
siderable number of brain tumors (Table 1) (17) and a
variety of other tumors (24,25) revealed that all the
tumors tested had activity and that some were consid-
erably higher than their normal tissue equivalents.
Induction of AT
In E. coli AT is highly inducible in response to ex-
posure to alkylating agents. As part of the adaptive
response increases ofseveral hundred fold occur within
a few hours of treatment with alkylating agents (36-
38). There is no clearly equivalent phenomenoninmam-
malian cells. Although some investigators have claimed
that small increases in AT occur in cultured cells ex-
posed to N-methyl-N'-nitro-N-nitrosoguanidine or N-
methyl-N-nitrosourea (39-41), these changes were at
most a few fold, and others using similar protocols have
failed to find any increase at all (42-44).
A more clearcut increase in AT activity occurs in the
livers of rats treated with dimethylnitrosamine (5,45-
48) orothernitrosamines orwith 1,2-dimethylhydrazine
(5,10,26,47). Such exposure results in about a3-fold rise
in AT (Table 2) but similar increases are produced by
exposure to otherhepatoxins which are notmetabolized
tosimple alkylatingagents (Table2) (10,49,50). An even
larger 6- to 7-fold increase in AT activity in rat liver
(Table 2) was observed in rat liver regenerating after
partialhepatectomy (11). These resultssuggestthatthe
increases in AT may be related to regenerative cell
replication and/or hormonal changes in response to the
toxic inducingagents. Evidence hasbeenpublished that
rat liver AT activity responds to both growth hormone
and thyroxin (51). The increased liver AT after hepa-
toxins and partial hepatectomy may, however, be lim-
ited to the rat. Attempts to induce hepatic AT in other
rodents (mice, gerbils, hamsters)byeithernitrosamines
orpartial hepatectomy hasbeenunsuccessful (2,52-54).
The small increase in hepatic AT in response to alkyl-
ating agents is, therefore, at present limited only to
rats and seems quite different from the adaptive
response.
Although AT is increased in rat liver hepatocytes
regeneratingafterpartialhepatectomythereisnooblig-
atory coupling between cell replication rates and the
AT level. The AT activity ofrat liver shortly afterbirth
is considerably lower than in the adult (Table 2) (51),
even though the hepatocytes in the neonatal rat are
dividing more rapidly. Similarly, the induction of AT
by 1,2-dimethylhydrazine occurs only in hepatocytes and
not in nonparenchymal cells (26) but the rate of DNA
synthesis is greater in the nonparenchymal cells. The
11006-ALKYLGUANINE-DNA ALKYLTRANSFERASE REPAIR
Table 2. Induction of rat liver 06-alkylguanine-DNA
alkyltransferase activity.a
Alkyltransferase
Treatment activity, fmole/mg
Control adult 93 ± 21
Dimethylnitrosamine
(2 mg/kg/day for 21 days) 224 ± 23
Diethylnitrosamine
(10 mg/kg/day for 21 days) 245 ± 49
1,2-Dimethylhydrazine
(3 mg/kg/day for 21 days) 247 ± 16
Partial hepatectomy
(48 hr after operation) 496 ± 68
Thioacetamide
(48 hr after 75 mg/kg) 185 ± 28
Carbon tetrachloride
(48 hr after 1.5 mL/kg) 199 ± 24
1 day old 24 ± 8
7 days old 53 ± 7
aData from references (10,11,51).
low level of AT in neonatal rat liver has recently been
confirmed by Ro et al. (55), and a very low activity of
AT in some human fetal tissues including liver was found
by Krokan and colleagues (56).
Specificity ofAlkyl Group Removal
The ability of the AT to remove alkyl groups of dif-
ferent sizes was tested using three different assay pro-
cedures (20,57). Radioactive substrates were used for
studies of methyl, ethyl, n-propyl, and isopropyl ad-
ducts by either the bacterial or mammalian AT. Studies
of 2-hydroxyethyl, n-butyl and isobutyl adducts were
carried out with unlabeled substrates. These 06-deriv-
atives could be quantitated after HPLC separation by
fluorescence detection and this assay was used for the
E. coli AT. However, this method was not sensitive
enough for studies ofthe rat liver AT which was avail-
able only in limited amounts. The activity of the rat
liver AT towards the substrates not available in a ra-
dioactive form were, therefore, carried out by use of a
competition assay. In this assay, the rat liver AT was
incubated with the unlabeled alkylated substrate for
varying amounts of time and then a radioactive meth-
ylated substrate was added and its repair was used to
estimate the amount ofAT activity remaining. A sum-
mary of the results is shown in Table 3. All of these
adducts could be removed from the O6-position ofguan-
ine bythe bacterial and mammalian AT. TheE. coli AT
which was very rapid on methyl groups was much slower
with the longer adducts. This result is in agreement
with the report by Lindahl and colleagues that ethyl
and 2-hydroxyethyl- groups are removed at least 100
times slower than methyl groups by the bacterial pro-
tein (32). Although the rat liverAT was also fasterwith
methyl groupsthanwithlargeradducts there wasmuch
less difference between the rates than with the E. coli
AT. For example, the E. coli AT removes n-propyl or
ethyl groups 50 to 100 times more slowly than methyl
Table 3. Substrate specificity of alkyltransferase
from rat liver and E. coli.
Alkyltransferase
activity, as time
Alkyl group at for 50% removal, min
06-position of guanine E. coli Rat liver
Methyl <0.5 <1
Ethyl 10 2
n-Propyl 15 3
n-Butyl 35 Substratea
Isopropyl >90 60
2-Hydroxyethyl >90 35
Isobutyl >90 Not tested
aRate not determined.
but the rat liver AT is only 3 to 4 times slower on these
adducts.
This finding has considerable practical importance in
the interpretation of studies of carcinogenesis by al-
kylating agents. When expressed in terms ofthe num-
berofDNAadductsformedatthe 06-positionofguanine
by carcinogenic doses, diethylnitrosamine is about 15
times more potent than dimethylnitrosamine (20,58). If
the formation and persistence until repair of 06-alkyl-
guanine in DNA were the only factorinvolved in tumor
initiation, the repair would have to be at least 15 times
slower which is not the case. This suggests that some
otherlesions, possibly04-alkylthymine(whichisformed
in greater amounts by ethylating than by methylating
agents), may be the critical lesion in cells such as he-
patocytes containing a high AT activity.
Another important consequence of these results is
that the rapid removal oflarger adducts from DNA by
the mammalian AT is likely to confer resistance to the
formation oflethal crosslinks by certain bifunctional al-
kylating agents (31-35). Such crosslink formation is
thought to involve an initial attack on the O6-position
ofguanine (forming a 2-chloroethyl adduct) which then
takes part in a slowerreaction leadingto a stable cross-
link. Ifthe 06-adduct is removed by the AT before this
reaction occurs the lethal lesion is prevented. The rel-
atively rapid removal oflonger chain adducts by the rat
liver AT should enable this to happen until the number
of lesions exceeds the amount of AT.
Finally, it was apparent that the AT could remove
branched adducts such asisopropyl fromthe O6-position
of DNA (Table 3), but that in the presence of DNA
substrates containing both n-propyl and isopropyl ad-
ducts (such as DNA reacted with N-n-propyl-N-nitro-
sourea), the protein shows a marked preference for the
linear derivative and the isopropyl groups start to be
the lost only when most ofthe n-propylis already gone.
Specificity of the Alkylated Base Substrate
Recent studies on the adaptive response in E. coli
(37,38) have indicated that the initial AT protein syn-
thesized by the bacteria is considerably larger than the
product of18,000 molecular weight which has been pur-
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Table 4. Removal of 04-methylthymine from methylated poly(dT)
by E. coli but not by rat liver alkyltransferase.a
Methylated poly(dT) Standard methylated
substrate, DNA substrate,
Alkyltransferase 04-methylthymine, 06-methylguanine,
added pmole pmole
E. coli 0.05 0.05
Rat liver 0.57 0.06
None 0.56 0.58
aThe AT preparation were incubated with either the methylated
poly(dT) containing 04-methylthymine or the standard methylated
calfthymus DNA containing 06-methylguanine and the content ofthe
methylated base determined after 60 min incubation.
ified to homogenicity and studied extensively (12). Fur-
thermore, the largerAT protein and possibly additional
methyltransferases which have not yet been fully char-
acterized can act not only on 06-methylguanine in DNA
but can also remove methyl groups from phosphotries-
ters and 04-methylthymine (59-61). The 18,000 molec-
ular weight protein (which is formed from the larger
precursors by an unknown mechanism) can also use 04-
methylthymine as a substrate (21,60). As shown in Ta-
ble 4, this bacterial AT can repair 04-methylthymine in
a methylated poly(dT)-poly(dA) substrate, but the rat
liver AT did not catalyze this reaction. These results
suggest that there is an important difference between
the two proteins and provide a possible mechanism by
which 04-alkylthymine but not 06-alkylguanine might
accumulate in mammalian cells exposed to alkylating
agents (62,63).
Itis conceivable that experiments carried out invitro
with a methylated poly(dT) substrate do not accurately
reflect the specificity of the protein towards the alky-
lated double stranded DNA which would occur in vivo.
It has been relatively difficult to test the AT activity
towards 04-methylthymine in such a substrate because
there is a much greater amount of 06-methylguanine
(about 100 times more) and the added AT is used up on
the06-adduct. However, inrecentexperimentsinwhich
a substantial excess of AT was used no significant loss
of04-methylthymine was brought about by the ratliver
AT under conditions where more than 95% of the O6_
methylguanine was demethylated. The E. coli AT re-
moved both 04-methylthymine and 06-methylguanine
from this substrate. Experiments with AT from human
fibroblasts have also been carried out, and a crude AT
extract from these cells did not remove 04-methylthy-
mine from methylated poly(dT) (19). There is, there-
fore, a striking and unexpected difference between the
bacterial and mammalian AT in that only the former
can work on 04-methylthymine as well as 06-methyl-
guanine. This difference andthat described above inthe
rate of removal of longer chain adducts from the O6-
position of guanine suggest that the bacterial AT may
not be an appropriate model for extrapolation to situ-
ations involving mutagenesis or carcinogenesis in mam-
malian cells.
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